Press coverage about Cutera (NASDAQ:CUTR) has been trending somewhat positive on Friday, according to Alpha One Sentiment. The research firm, a service of Accern, rates the sentiment of media coverage by reviewing more than 20 million blog and news sources in real-time. Alpha One ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cutera earned a coverage optimism score of 0.13 on Alpha One’s scale. Alpha One also gave press coverage about the medical device company an impact score of 16 out of 100, indicating that recent media coverage is very unlikely to have an impact on the company’s share price in the near term.
Here are some of the media headlines that may have effected AlphaOne Sentiment’s rankings:
- Cutera, Inc. (CUTR) Given Average Rating of “Strong Buy” by Analysts (americanbankingnews.com)
- Insider Selling: Cutera, Inc. (CUTR) EVP Sells 2,563 Shares of Stock (americanbankingnews.com)
- Noteworthy Monday Option Activity: CUTR, PKG, NEWR (stockoptionschannel.com)
- ‘Tough for South Africa when AB de Villiers doesn’t perform’ (fumbleboard.com)
Shares of Cutera (NASDAQ CUTR) traded up 1.74% on Friday, hitting $23.35. The stock had a trading volume of 146,041 shares. The firm has a market capitalization of $323.58 million, a P/E ratio of 89.46 and a beta of 0.62. Cutera has a 12-month low of $10.42 and a 12-month high of $24.78. The company has a 50 day moving average of $21.67 and a 200-day moving average of $19.80.
Cutera (NASDAQ:CUTR) last released its quarterly earnings results on Monday, May 1st. The medical device company reported ($0.07) earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.07). The firm had revenue of $29.30 million during the quarter, compared to the consensus estimate of $29 million. Cutera had a net margin of 2.89% and a return on equity of 9.21%. The company’s revenue for the quarter was up 30.8% on a year-over-year basis. During the same quarter last year, the firm earned ($0.16) earnings per share. Equities analysts predict that Cutera will post $0.47 EPS for the current fiscal year.
Several research analysts have recently commented on CUTR shares. Zacks Investment Research raised Cutera from a “hold” rating to a “strong-buy” rating and set a $24.00 target price on the stock in a report on Thursday, February 16th. Sidoti started coverage on Cutera in a report on Tuesday, April 11th. They issued a “buy” rating and a $27.00 target price on the stock. Finally, TheStreet downgraded Cutera from a “b-” rating to a “c” rating in a report on Monday, May 1st.
TRADEMARK VIOLATION WARNING: “Somewhat Favorable Press Coverage Very Unlikely to Affect Cutera (CUTR) Share Price” was originally reported by WKRB News and is the property of of WKRB News. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.wkrb13.com/markets/2229293/somewhat-favorable-press-coverage-very-unlikely-to-affect-cutera-cutr-share-price.html.
In other news, EVP Larry Laber sold 2,563 shares of the firm’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $24.36, for a total transaction of $62,434.68. Following the completion of the transaction, the executive vice president now owns 74,203 shares of the company’s stock, valued at $1,807,585.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David A. Gollnick sold 39,204 shares of the firm’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $22.31, for a total transaction of $874,641.24. Following the transaction, the director now directly owns 34,136 shares of the company’s stock, valued at approximately $761,574.16. The disclosure for this sale can be found here. Insiders have sold 158,910 shares of company stock valued at $3,324,504 in the last ninety days. Insiders own 11.60% of the company’s stock.
Cutera, Inc is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2229293/somewhat-favorable-press-coverage-very-unlikely-to-affect-cutera-cutr-share-price.html
Receive News & Ratings for Cutera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.